Panel Upholds Board, Continues To Disagree On Impact Of Arthrex

Mealey's (November 20, 2019, 1:14 PM EST) -- WASHINGTON, D.C. — A panel majority of the Federal Circuit U.S. Court of Appeals on Nov. 19 affirmed that two patents relating to manmade insulin are obvious, but a dissenting judge...
To view the full article, register now.